An overview of how psychological treatAn overview of how psychological treatments might best be deployed in early ments might best be deployed in early schizophrenia can be framed in the context schizophrenia can be framed in the context of what is known about prognostic factors of what is known about prognostic factors in first-episode schizophrenia. A range of in first-episode schizophrenia. A range of these has been established from follow-up these has been established from follow-up studies, although most factors, such as studies, although most factors, such as family history of psychosis, are not changefamily history of psychosis, are not changeable. Table 1 lists those replicated predicable. Table 1 lists those replicated predictors of outcome for which an intervention tors of outcome for which an intervention is at least plausible. Discussion of interis at least plausible. Discussion of interventions will be considered alongside these ventions will be considered alongside these known outcome predictors. known outcome predictors.
In general, individual psychological In general, individual psychological treatments have been evaluated in estabtreatments have been evaluated in established schizophrenia, where they have been lished schizophrenia, where they have been delivered alongside routine care, in particudelivered alongside routine care, in particular, drug treatment. There are particular lar, drug treatment. There are particular issues in early schizophrenia, some of which issues in early schizophrenia, some of which parallel drug treatment issues. Are potential parallel drug treatment issues. Are potential longer-term gains greater in first-episode longer-term gains greater in first-episode schizophrenia possibly preventing the emerschizophrenia possibly preventing the emergence of more chronic functional deficits? gence of more chronic functional deficits? Might they be effective in preventing or postMight they be effective in preventing or postponing first relapse? Are they only effective poning first relapse? Are they only effective during the treatment period or do they during the treatment period or do they confer lasting benefit: how long should they confer lasting benefit: how long should they be continued? How is it best to integrate be continued? How is it best to integrate drug and psychological treatments? Can psydrug and psychological treatments? Can psychological treatments ever be an alternative chological treatments ever be an alternative to drug treatments, rather than an adjunct? to drug treatments, rather than an adjunct?
FAMILY ENVIRONMENT FAMILY ENVIRONMENT AND FAMILY AND FAMILY INTERVENTIONS INTERVENTIONS
One well-replicated predictor of outcome is One well-replicated predictor of outcome is family environment. Early studies showed family environment. Early studies showed that patients persistently exposed to families that patients persistently exposed to families who speak about them in emotional and who speak about them in emotional and critical terms have higher relapse rates critical terms have higher relapse rates (Vaughan & Leff, 1976) . A recent meta- (Vaughan & Leff, 1976) . A recent metaanalysis of 27 studies supports this (Butzlaff analysis of 27 studies supports this (Butzlaff & Hooley, 1998) . This 'expressed emotion ' & Hooley, 1998) . This 'expressed emotion' (in particular criticism) is a core target for (in particular criticism) is a core target for these interventions. The most effective these interventions. The most effective family interventions have a cognitivefamily interventions have a cognitivebehavioural basis and common features. behavioural basis and common features. One is education about the illness, sympOne is education about the illness, symptoms and their likely effects, such as avolitoms and their likely effects, such as avolition and consequent inactivity. Another is tion and consequent inactivity. Another is promotion of a problem-solving approach. promotion of a problem-solving approach. Problems are identified, their causes and Problems are identified, their causes and consequences clarified and families are consequences clarified and families are encouraged to develop strategies to combat encouraged to develop strategies to combat them. A third feature of effective interventhem. A third feature of effective interventions is that they address the problems tions is that they address the problems families may have in coming to terms with families may have in coming to terms with the guilt and anger they may experience at the guilt and anger they may experience at the patient's diagnosis and illness, and the the patient's diagnosis and illness, and the challenge to their expectations for the challenge to their expectations for the patient. A fourth feature is that they include patient. A fourth feature is that they include the patient and address the family atmosthe patient and address the family atmosphere itself, by identifying sources of stress phere itself, by identifying sources of stress within the family and identifying ways of within the family and identifying ways of alleviating them. Assessing systematically alleviating them. Assessing systematically the unmet needs of family members can be the unmet needs of family members can be helpful (Barrowclough helpful (Barrowclough et al et al, 1999; Sellwood , 1999; Sellwood et al et al, 2001) . Finally, it is important to in-, 2001) . Finally, it is important to include the patient sufficiently often and have clude the patient sufficiently often and have enough sessions. Most interventions of this enough sessions. Most interventions of this type have monthly or twice monthly sestype have monthly or twice monthly sessions for 6-9 months. Groups of families sions for 6-9 months. Groups of families have been treated successfully and costhave been treated successfully and costeffectively (McFarlane effectively (McFarlane et al et al, 1995) . , 1995).
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Integrating non-drug treatments in early Integrating non-drug treatments in early schizophrenia schizophrenia SHON W. LE WIS, NICOLAS TARRIER and RICHARD J. DRAKE SHO " N W. LEWIS, NICOLAS TARRIER and RICHARD J. DRAKE (Kemp et al et al, 1996 (Kemp et al et al, , 1998 (Kemp et al et al, ) , 1996 (Kemp et al et al, , 1998 , 2001 ). The main measure of outcome used in family intervention studies outcome used in family intervention studies has been reduction in relapse rates. The has been reduction in relapse rates. The overall effective size in the Cochrane review overall effective size in the Cochrane review of randomised, controlled trials (0.2) was of randomised, controlled trials (0.2) was smaller than that in interventions of the smaller than that in interventions of the type described above but it included less eftype described above but it included less effective designs in the analysis. Studies sharfective designs in the analysis. Studies sharing the features described tend to reduce ing the features described tend to reduce relapse rate by up to 40% compared with relapse rate by up to 40% compared with controls over follow-up periods of 9-18 controls over follow-up periods of 9-18 months, representing an effect size of about months, representing an effect size of about 0.4. Those who benefit show improved ad-0.4. Those who benefit show improved adherence to medication and their families herence to medication and their families have reduction in expressed emotion. The have reduction in expressed emotion. The benefits in some studies (Tarrier benefits in some studies (Tarrier et al et al, , 1993) have continued up to 8 years, but 1993) have continued up to 8 years, but diminished over time. diminished over time.
Family interventions in the first episode Family interventions in the first episode have not been widely evaluated, although have not been widely evaluated, although there is good reason to expect that they there is good reason to expect that they should be effective (Goldstein, 1996) . The should be effective (Goldstein, 1996) . The most informative trial was that of Lenior most informative trial was that of Lenior et al et al (2001) who randomised 64 patients (2001) who randomised 64 patients with early schizophrenia, 55% in their first with early schizophrenia, 55% in their first episode, to receive family intervention or episode, to receive family intervention or routine care alone. Relapse rates were routine care alone. Relapse rates were reduced during the actual 12-month experireduced during the actual 12-month experimental treatment period, but did not differ mental treatment period, but did not differ significantly between the two groups at significantly between the two groups at 5-year follow-up, although the total time 5-year follow-up, although the total time spent in in-patient care was reduced in the spent in in-patient care was reduced in the family intervention group. family intervention group.
SUBSTANCE MISUSE SUBSTANCE MISUSE AND MOTIVATIONAL AND MOTIVATIONAL INTERVENTIONS INTERVENTIONS
It is clear that drug misuse increases relapse It is clear that drug misuse increases relapse risk in schizophrenia and may even risk in schizophrenia and may even constitute a risk factor for the disorder itself constitute a risk factor for the disorder itself (Arsenault (Arsenault et al et al, 2002; Zammit , 2002; Zammit et al et al, 2002) . , 2002). Cannabis and amphetamine-like drugs Cannabis and amphetamine-like drugs appear particularly toxic in this regard. In appear particularly toxic in this regard. In the first-episode follow-up study of Linszen the first-episode follow-up study of Linszen et al et al (1994) , those people who used signifi-(1994), those people who used significant amounts of cannabis showed a twofold cant amounts of cannabis showed a twofold increase in relapse rates over the next year, increase in relapse rates over the next year, compared with those people who used small compared with those people who used small amounts or none. People with schizoamounts or none. People with schizophrenia who misuse substances ('dual diagphrenia who misuse substances ('dual diagnosis') represent a special challenge since nosis') represent a special challenge since services are poorly configured to deal with services are poorly configured to deal with both problems and the evidence base for both problems and the evidence base for drug and drug and psychological interventions is psychological interventions is sparse. There is anecdotal evidence that closparse. There is anecdotal evidence that clozapine can reduce drug misuse in schizozapine can reduce drug misuse in schizophrenia (Drake phrenia (Drake et al et al, 2000) , perhaps by , 2000), perhaps by the same mechanism that it appears to the same mechanism that it appears to reduce other areas of impulsive behaviour reduce other areas of impulsive behaviour in schizophrenia, such as violence and in schizophrenia, such as violence and deliberate self-harm (Buckley deliberate self-harm (Buckley et al et al, 2003) . , 2003). The only therapeutic trial of an effective The only therapeutic trial of an effective patient-level intervention is that of Barrowpatient-level intervention is that of Barrowclough clough et al et al (2001) . Here, patients (not (2001) . Here, patients (not first-episode) with dual diagnosis were ranfirst-episode) with dual diagnosis were randomised to routine care or to a psychological domised to routine care or to a psychological treatment package of motivational intertreatment package of motivational interviewing directed at reducing the substance viewing directed at reducing the substance misuse, cognitive therapy aimed at psychotic misuse, cognitive therapy aimed at psychotic symptom control and family intervention. symptom control and family intervention. Motivational interviewing has been used to Motivational interviewing has been used to treat uncomplicated substance dependence. treat uncomplicated substance dependence. Patients are encouraged to explore the Patients are encouraged to explore the problems their substance misuse causes and problems their substance misuse causes and the ways in which it prevents them achieving the ways in which it prevents them achieving their goals. They are also encouraged to their goals. They are also encouraged to explore how they could address these explore how they could address these problems, including reduction in substance problems, including reduction in substance misuse, strategies for relapse prevention misuse, strategies for relapse prevention and possibly engagement with services and and possibly engagement with services and use of drugs to reduce craving or block the use of drugs to reduce craving or block the effects of illicit drugs. The results of the trial effects of illicit drugs. The results of the trial showed at 12 months a significant increase showed at 12 months a significant increase in global functioning, and a halving in in global functioning, and a halving in relapse rates from 56% to 28% in the relapse rates from 56% to 28% in the experimental group (Haddock experimental group (Haddock et al et al, 2003 
DRUG TREATMENT DRUG TREATMENT NON-ADHERENCE NON-ADHERENCE AND COMPLIANCE THER APY AND COMPLIANCE THER APY
Motivational interviewing aimed at reduMotivational interviewing aimed at reducing misuse is a good example of a psychocing misuse is a good example of a psychological treatment whose effect is mediated logical treatment whose effect is mediated by explicitly reducing a known risk factor. by explicitly reducing a known risk factor. Similar techniques have been used in atSimilar techniques have been used in attempts to improve outcomes by enhancing tempts to improve outcomes by enhancing a known protective factor, antipsychotic a known protective factor, antipsychotic drug treatment. People in the first episode drug treatment. People in the first episode of schizophrenia respond well to low doses of schizophrenia respond well to low doses of medication, but are sensitive to the of medication, but are sensitive to the adverse effects (Remington adverse effects (Remington et al et al, 1998 (Remington et al et al, ), , 1998 , which contribute to high rates of nonwhich contribute to high rates of nonadherence to maintenance drug treatment adherence to maintenance drug treatment and consequent poor outcome (Verdoux and consequent poor outcome (Verdoux et al et al, 2000) . , 2000). Kemp Kemp et al et al (1998) used a form of ther-(1998) used a form of therapy derived from motivational interviewing apy derived from motivational interviewing to enhance adherence to medication. In a to enhance adherence to medication. In a clinical trial, patients admitted for acute clinical trial, patients admitted for acute relapse (not in the first episode) were relapse (not in the first episode) were randomised to receive routine care or randomised to receive routine care or routine care plus a brief package of motivaroutine care plus a brief package of motivational interviewing, adapted for those with tional interviewing, adapted for those with schizophrenia and concentrating on ways schizophrenia and concentrating on ways to treat symptoms, reduce problems and to treat symptoms, reduce problems and prevent relapse using antipsychotic mediprevent relapse using antipsychotic medication. The experimental group showed cation. The experimental group showed clinically and statistically significant reducclinically and statistically significant reduction in readmission rates and improvements tion in readmission rates and improvements in compliance over 18 months, and in compliance over 18 months, and improvements in symptoms at the end of improvements in symptoms at the end of therapy but not after 18 months. therapy but not after 18 months.
NEUROCOGNITIVE NEUROCOGNITIVE DEFICITS AND COGNITIVE DEFICITS AND COGNITIVE REMEDIATION REMEDIATION
There are well-replicated neurocognitive There are well-replicated neurocognitive deficits in schizophrenia. Most evidence deficits in schizophrenia. Most evidence supports the existence of deficits in working supports the existence of deficits in working memory and executive function and these memory and executive function and these deficits strongly predict outcome (Green, deficits strongly predict outcome (Green, 1996) . Still at issue is the natural history 1996). Still at issue is the natural history of these deficits. Individuals at high genetic of these deficits. Individuals at high genetic risk for schizophrenia show deficits in risk for schizophrenia show deficits in motor coordination, attention and execumotor coordination, attention and executive function, in particular (e.g. Hans tive function, in particular (e.g. Hans et al et al, , 1999; Byrne 1999; Byrne et al et al, 2000; Erlenmeyer-, 2000; ErlenmeyerKimling Kimling et al et al, 2000) . There is some , 2000). There is some evidence that at the onset of positive evidence that at the onset of positive symptoms such individuals also show symptoms such individuals also show decrements in neurocognitive function, in decrements in neurocognitive function, in dorsolateral prefrontal cortical tasks, in dorsolateral prefrontal cortical tasks, in particular (Bilder particular (Bilder et al et al, 1992; Cosway , 1992; Cosway et et al al, 2000) . There is mixed evidence about , 2000). There is mixed evidence about the effect of long periods without treatthe effect of long periods without treatment, some of which shows greater detement, some of which shows greater deterioration in frontal tests ( , 2002) . A 10-year follow-up study of a consecutively 10-year follow-up study of a consecutively ascer ascertained cohort of 110 patients with tained cohort of 110 patients with firstfirst-episode psychosis has shown that episode psychosis has shown that executive function tends to improve but executive function tends to improve but progressive visuospatial deficits emerge; progressive visuospatial deficits emerge; the scale of both these changes predicts the scale of both these changes predicts long-term clinical outcome (Stirling long-term clinical outcome (Stirling et al et al, , 2003) . Other follow-up studies over the 2003). Other follow-up studies over the short to medium term in early schizoshort to medium term in early schizophrenia have shown little or no change in phrenia have shown little or no change in cognitive function (Rund, 1998) . cognitive function (Rund, 1998) .
Cognitive remediation centres on direct Cognitive remediation centres on direct remediation of the cognitive deficits that remediation of the cognitive deficits that are presumed to lead to symptoms and difare presumed to lead to symptoms and difficulty in social function (Brenner ficulty in social function (Brenner et al et al, , 1994) . For some years this approach has 1994). For some years this approach has demonstrated limited success, with a failure demonstrated limited success, with a failure of any benefits in cognitive function to feed of any benefits in cognitive function to feed through into improved social function, but through into improved social function, but recently more refined models of cognitive recently more refined models of cognitive deficits and improvements in tailoring deficits and improvements in tailoring training to those with schizophrenia have training to those with schizophrenia have suggested greater benefits may be realised. suggested greater benefits may be realised. In a small sample, Wykes In a small sample, Wykes et al et al (1999, (1999, 2003) used techniques, such as errorless 2003) used techniques, such as errorless learning (in which tasks are taught taking learning (in which tasks are taught taking care to avoid the subject being confused care to avoid the subject being confused by making mistakes), scaffolding (where by making mistakes), scaffolding (where strategies are demonstrated to subjects initistrategies are demonstrated to subjects initially but gradually support is reduced) and ally but gradually support is reduced) and massed practice (repeated exercises at least massed practice (repeated exercises at least 3-5 times per week) to produce persistent 3-5 times per week) to produce persistent gains in executive function, memory and gains in executive function, memory and self-esteem. self-esteem.
Patterns of cognitive deficit relate to a Patterns of cognitive deficit relate to a greater or lesser extent to symptomatology greater or lesser extent to symptomatology and an extension of cognitive remediation and an extension of cognitive remediation to early schizophrenia may be the targeting to early schizophrenia may be the targeting of individual deficits that relate to core, of individual deficits that relate to core, emerging symptoms. Poor insight is one imemerging symptoms. Poor insight is one important clinical example, where there is portant clinical example, where there is mounting evidence of an association with mounting evidence of an association with a specific executive neurocognitive taska specific executive neurocognitive taskset-shifting. Drake & Lewis (2003) found set-shifting. Drake & Lewis (2003) found set-shifting errors involving perseveration set-shifting errors involving perseveration to be strongly linked to the core component to be strongly linked to the core component of poor insight, the inability to relabel of poor insight, the inability to relabel symptoms, in a sample with predominantly symptoms, in a sample with predominantly first-episode psychosis, leading to the profirst-episode psychosis, leading to the proposal that defective self-monitoring contriposal that defective self-monitoring contributes both to perseveration and poor butes both to perseveration and poor insight. Koren and colleagues (Viksman insight. Koren and colleagues (Viksman et et al al, 2002) similarly confirmed that good in-, 2002) similarly confirmed that good insight in the first episode was linked to the sight in the first episode was linked to the ability to act appropriately on the basis of ability to act appropriately on the basis of self-monitoring. , 2003) , suggesting that the most gains in 2003), suggesting that the most gains in outcome will be realised by reducing the outcome will be realised by reducing the duration of untreated psychosis further duration of untreated psychosis further in cases where it is already fairly brief. in cases where it is already fairly brief. Service-level interventions are those that Service-level interventions are those that will allow early detection. The individual will allow early detection. The individual components of the intervention should components of the intervention should probably include cognitive-behavioural probably include cognitive-behavioural therapy (CBT). therapy (CBT).
Individual CBT has generated a sizeable Individual CBT has generated a sizeable body of evidence, although the first trials in body of evidence, although the first trials in this area were undertaken only 10 years this area were undertaken only 10 years ago. The accepted findings are that CBT, ago. The accepted findings are that CBT, if delivered over a period of at least 6 if delivered over a period of at least 6 months, will reduce positive and to some months, will reduce positive and to some extent negative symptoms in otherwise extent negative symptoms in otherwise treatment-resistant schizophrenia. In these treatment-resistant schizophrenia. In these trials, as with all others so far, CBT has trials, as with all others so far, CBT has been delivered as an adjunct to drug treatbeen delivered as an adjunct to drug treatment as usual. A convergence between inment as usual. A convergence between independent randomised controlled trials in dependent randomised controlled trials in this patient group is striking. Four good this patient group is striking. Four good quality trials (Tarrier quality trials (Tarrier et al et al, 1993 (Tarrier et al et al, , 1998 , 1993 , 1998 Kuipers Kuipers et al et al, 1997; Sensky , 1997; Sensky et al et al, 2000) , 2000) have used similar inclusion criteria with have used similar inclusion criteria with similar experimental treatments in terms similar experimental treatments in terms of content and duration. The trials have of content and duration. The trials have differed in other respects, particularly the differed in other respects, particularly the selection and rationale of control intervenselection and rationale of control interventions and the use or otherwise of blinded tions and the use or otherwise of blinded assessments of outcome. The effect size assessments of outcome. The effect size for improvement of positive symptoms in for improvement of positive symptoms in these trials is about 0.6. The effect of the these trials is about 0.6. The effect of the intervention extends to improvement in intervention extends to improvement in negative symptoms and, in some circumnegative symptoms and, in some circumstances, social functioning. In addition, stances, social functioning. In addition, the effect appears to be durable at 6-9 the effect appears to be durable at 6-9 months post-treatment and beyond. The months post-treatment and beyond. The patient population identified for these trials patient population identified for these trials is closely similar to that used in the earlier is closely similar to that used in the earlier clozapine efficacy studies and the effect clozapine efficacy studies and the effect size, according to systematic review, is not size, according to systematic review, is not dissimilar (Wahlbeck dissimilar (Wahlbeck et al et al, 2000) . An , 2000) . An important statistical issue here is that the important statistical issue here is that the population and the samples for these trials population and the samples for these trials are selected on the basis of having persisare selected on the basis of having persistent and stable positive symptoms, so maxtent and stable positive symptoms, so maximising the power of a trial to test the imising the power of a trial to test the efficacy of an add-on treatment. Taking as its starting point the demonstrated effectiveness of CBT in demonstrated effectiveness of CBT in schizophrenia patients with persistent, schizophrenia patients with persistent, treatment-resistant symptoms, the hypothtreatment-resistant symptoms, the hypotheses of this trial were that CBT, in addition eses of this trial were that CBT, in addition to routine care (drugs), would accelerate to routine care (drugs), would accelerate resolution of acute symptoms in firstresolution of acute symptoms in firstepisode schizophrenia, improve 18-month episode schizophrenia, improve 18-month outcomes and delay future relapse. Conseoutcomes and delay future relapse. Consecutive first-or second-episode acute incutive first-or second-episode acute inpatient or day patient admissions with patient or day patient admissions with DSM-IV (American Psychiatric Assocation, DSM-IV (American Psychiatric Assocation, 1994) schizophrenia-spectrum psychoses 1994) schizophrenia-spectrum psychoses were randomised into the trial from 11 were randomised into the trial from 11 centres. Consenting subjects were randomcentres. Consenting subjects were randomised within 14 days to one of three treatised within 14 days to one of three treatment arms. The experimental treatment ment arms. The experimental treatment was a 5-week package of CBT, plus three was a 5-week package of CBT, plus three boosters over 3 months, in addition to boosters over 3 months, in addition to routine care. A second psychological treatroutine care. A second psychological treatment arm aimed to control for non-specific ment arm aimed to control for non-specific therapist effects and involved supportive therapist effects and involved supportive counselling over a similar period plus counselling over a similar period plus routine care. The third arm was routine routine care. The third arm was routine care alone. Outcome assessments were care alone. Outcome assessments were made blind to treatment group and were made blind to treatment group and were performed weekly over the first 6 weeks, performed weekly over the first 6 weeks, then at 9 and 18 months. then at 9 and 18 months.
Interventions were commenced within Interventions were commenced within 3 days of randomisation and in the case 3 days of randomisation and in the case of the CBT and supportive counselling of the CBT and supportive counselling were manual-based and supervised. In addiwere manual-based and supervised. In addition, psychological treatment sessions were tion, psychological treatment sessions were audiotaped and rated masked to evaluate audiotaped and rated masked to evaluate and confirm treatment fidelity. The ranand confirm treatment fidelity. The randomised sample for analysis was 309 domised sample for analysis was 309 patients: 101 patients received CBT, 106 patients: 101 patients received CBT, 106 received supportive counselling and 102 received supportive counselling and 102 received routine care alone. The median received routine care alone. The median age of the sample was 27.4 years, 70% age of the sample was 27.4 years, 70% were male and 83% were in their first were male and 83% were in their first admission. Mean total score on the Positive admission. Mean total score on the Positive and Negative Syndrome Scale (PANSS; Kay and Negative Syndrome Scale (PANSS; Kay et al et al, 1987) at baseline was 87, confirming , 1987) at baseline was 87, confirming that this was a severely ill sample. Blind that this was a severely ill sample. Blind assessments over the first 6 weeks showed assessments over the first 6 weeks showed s 6 7 s 6 7 a trend towards more rapid resolution of a trend towards more rapid resolution of acute symptoms in the CBT groups. acute symptoms in the CBT groups.
Post hoc Post hoc analyses confirmed that the analyses confirmed that the CBT group was significantly more im-CBT group was significantly more improved than the routine care group at 4 proved than the routine care group at 4 weeks on PANSS positive symptom and deweeks on PANSS positive symptom and delusion scale scores, but that this effect had lusion scale scores, but that this effect had disappeared by 6 weeks (Lewis disappeared by 6 weeks (Lewis et al et al, , 2002) . Follow-up at 18 months showed 2002). Follow-up at 18 months showed that the group who had received CBT in that the group who had received CBT in the first 5 weeks had a significantly lower the first 5 weeks had a significantly lower PANSS total score ( PANSS total score (P P¼0.03; effect size 0.03; effect size 0.44) and lower PANSS positive score 0.44) and lower PANSS positive score ( (P P¼0.01; effect size 0.43) than the routine 0.01; effect size 0.43) than the routine care group, after adjusting for baseline care group, after adjusting for baseline score, time to assessment, clinical centre, score, time to assessment, clinical centre, sex, in-patient sex, in-patient v.
v. day patient status, firstday patient status, firstv. v. second-episode psychosis and duration second-episode psychosis and duration of untreated psychosis at baseline. On the of untreated psychosis at baseline. On the primary outcome measures at 18 months, primary outcome measures at 18 months, the supportive counselling group showed the supportive counselling group showed symptom scores intermediate between the symptom scores intermediate between the CBT and routine care groups (Tarrier CBT and routine care groups (Tarrier et et al al, 2004) . Analysis of relapse and readmis-, 2004). Analysis of relapse and readmission rates showed that the experimental sion rates showed that the experimental treatment had no affect on this measure. treatment had no affect on this measure.
The overall conclusions from this trial The overall conclusions from this trial were that a brief package of CBT in acute were that a brief package of CBT in acute early schizophrenia accelerated improveearly schizophrenia accelerated improvement in target symptoms but that these ment in target symptoms but that these gains were lost by 6 weeks, perhaps due gains were lost by 6 weeks, perhaps due to the powerful main effect of routine care, to the powerful main effect of routine care, i.e. drug treatment. The intervention also i.e. drug treatment. The intervention also led to improved symptomatic outcomes at led to improved symptomatic outcomes at 18 months compared with routine care 18 months compared with routine care alone. However, these effects were small, alone. However, these effects were small, although measurable and durable, and although measurable and durable, and there is no effect on time to relapse. there is no effect on time to relapse.
THE INTERFACE BETWEEN THE INTERFACE BETWEEN DRUG AND PSYCHOLOGICAL DRUG AND PSYCHOLOGICAL TREATMENTS TREATMENTS

Methodological issues Methodological issues
The results of these trials have been taken The results of these trials have been taken up enthusiastically by a clinical community up enthusiastically by a clinical community looking for alternative strategies to drug looking for alternative strategies to drug treatments, on the basis of their intellectual treatments, on the basis of their intellectual appeal. It is not surprising that people with, appeal. It is not surprising that people with, or caring for those with, severe psychoor caring for those with, severe psychological symptoms should expect treatments logical symptoms should expect treatments based on primary psychological approaches based on primary psychological approaches to be available. However, it is important to to be available. However, it is important to recognise methodological limitations in this recognise methodological limitations in this area, particularly those that might in some area, particularly those that might in some circumstances lead to a type 1 statistical circumstances lead to a type 1 statistical error. In broad terms, these limitations error. In broad terms, these limitations can be divided into general design issues can be divided into general design issues for randomised controlled trials and those for randomised controlled trials and those involving theoretical issues about the involving theoretical issues about the content of the treatment itself. These areas content of the treatment itself. These areas overlap. overlap.
The generally desirable features of a The generally desirable features of a clinical trial are shown in the Appendix. clinical trial are shown in the Appendix. In general, it can be argued that the ground In general, it can be argued that the ground rules for establishing the effectiveness of rules for establishing the effectiveness of psychological treatment should be no psychological treatment should be no different from those used to establish the different from those used to establish the effectiveness of pharmacological therapy. effectiveness of pharmacological therapy. However, there are a number of challenges However, there are a number of challenges in evaluating psychological treatments that in evaluating psychological treatments that are not present in drug trials. Cognitiveare not present in drug trials. Cognitivebehavioural therapy, unlike drug treatbehavioural therapy, unlike drug treatment, involves modifying behavioural ment, involves modifying behavioural contingencies and the cognitive architecture. contingencies and the cognitive architecture.
Looking at specific issues, the use of a Looking at specific issues, the use of a double-blind design, as is the benchmark double-blind design, as is the benchmark approach in phase III clinical trials of a approach in phase III clinical trials of a drug treatment, is not possible with psychodrug treatment, is not possible with psychological treatments. This makes it more, logical treatments. This makes it more, rather than less, important that when a rather than less, important that when a masked parameter is possible, it is used. masked parameter is possible, it is used. There have been debates about whether or There have been debates about whether or not it is possible to maintain masking to not it is possible to maintain masking to treatment allocation when assessing outtreatment allocation when assessing outcome. Because of the known potency of come. Because of the known potency of the use of open assessments in introducing the use of open assessments in introducing bias, it is vital to attempt to use indepenbias, it is vital to attempt to use independent, masked assessments of outcome, with dent, masked assessments of outcome, with assessment of the quality of the masking if assessment of the quality of the masking if possible. In addition, the choice of outpossible. In addition, the choice of outcomes should include those which are relacomes should include those which are relatively impervious to the effects of masking, tively impervious to the effects of masking, such as relapse, hospitalisation and instrusuch as relapse, hospitalisation and instrumental outcomes, such as employment mental outcomes, such as employment status. status.
The choice of control group in these The choice of control group in these studies is also important. The choice should studies is also important. The choice should be based on the hypothesis of the study and be based on the hypothesis of the study and take into account that, in general, psychotake into account that, in general, psychological treatments are used in addition to logical treatments are used in addition to treatment as usual, rather than an alternatreatment as usual, rather than an alternative. The hypothesis in this area is usually tive. The hypothesis in this area is usually that CBT has a specific effect over and that CBT has a specific effect over and above a supportive counselling approach. above a supportive counselling approach. Ideally, this means the use of two control Ideally, this means the use of two control groups, one controlling for non-specific groups, one controlling for non-specific effects of talking treatments (Lewis effects of talking treatments (Lewis et al et al, , 2002 (Lewis et al et al, , ). 2002 .
There has been a trend of late to focus There has been a trend of late to focus on pragmatic trials in healthcare evaluaon pragmatic trials in healthcare evaluations generally. These are trials which tend tions generally. These are trials which tend to be large with simple outcomes that solely to be large with simple outcomes that solely address the question of effectiveness. It can address the question of effectiveness. It can be argued that in an area such as psychobe argued that in an area such as psychological treatments of psychosis it is vital to logical treatments of psychosis it is vital to derive treatments from a sound theoretical derive treatments from a sound theoretical base and build into the trial design an base and build into the trial design an explanatory component to test whether this explanatory component to test whether this hypothesised mechanism is actually that hypothesised mechanism is actually that which mediates any effect. One example which mediates any effect. One example of an alternative explanation would be that of an alternative explanation would be that the clinical effect of a psychological treatthe clinical effect of a psychological treatment is actually mediated inadvertently ment is actually mediated inadvertently through another therapeutic mechanism, through another therapeutic mechanism, such as improved adherence to drug treatsuch as improved adherence to drug treatments. Another important issue specific to ments. Another important issue specific to this area is replicability. With CBT, this this area is replicability. With CBT, this typically involves a range of psychological typically involves a range of psychological techniques focusing on different aspects of techniques focusing on different aspects of psychopathology. The emphasis, particupsychopathology. The emphasis, particularly in Europe, is for the approach to be larly in Europe, is for the approach to be individually tailored according to individindividually tailored according to individual clinical priorities and case formulation ual clinical priorities and case formulation (Tarrier & Calam, 2002) . In North (Tarrier & Calam, 2002) . In North America, the approach tends to be more a America, the approach tends to be more a standardised, less flexible, manualised standardised, less flexible, manualised approach. Issues of replicability are approach. Issues of replicability are important, given this situation. At the very important, given this situation. At the very least, the semi-objective demonstration of least, the semi-objective demonstration of treatment fidelity, i.e. that the treatment treatment fidelity, i.e. that the treatment given adheres to a written procedural given adheres to a written procedural protocol, is measured and reported. protocol, is measured and reported.
The prediction of response to the most The prediction of response to the most suitable interventions is one obvious area suitable interventions is one obvious area of further study. Further development of of further study. Further development of therapies like individual CBT and family intherapies like individual CBT and family intervention in the light of this, and investigatervention in the light of this, and investigation of the processes of therapy are others. tion of the processes of therapy are others. Development of cognitive remediation and Development of cognitive remediation and integration into other methods of social reintegration into other methods of social rehabilitation offers some promise. Investigahabilitation offers some promise. Investigation of compliance therapy and other tion of compliance therapy and other interventions delivered by other less highly interventions delivered by other less highly trained staff is important and potentially trained staff is important and potentially problematic because of the complex skills problematic because of the complex skills needed. Turkington needed. Turkington et al et al (2002) found a (2002) found a CBT programme delivered by trained com-CBT programme delivered by trained community nurses to patients and families was munity nurses to patients and families was effective in a randomised controlled trial. effective in a randomised controlled trial. Development of model programmes Development of model programmes integrating different approaches is also a integrating different approaches is also a current area of research, although the current area of research, although the weakness of many of these studies is that weakness of many of these studies is that it remains unclear which elements of it remains unclear which elements of complex programmes, sometimes given to complex programmes, sometimes given to heterogeneous samples, are effective. heterogeneous samples, are effective.
Results of trials of psychodynamic Results of trials of psychodynamic therapy have been discouraging (Mueser therapy have been discouraging (Mueser & Berenbaum, 1990 ) but a form of & Berenbaum, 1990) but a form of psychotherapy designed to address interpsychotherapy designed to address interpersonal and social difficulties without personal and social difficulties without overstimulating patients had mixed success overstimulating patients had mixed success (Hogarty (Hogarty et al et al, 1997 (Hogarty et al et al, , 1997a . Relapse rates ). Relapse rates were reduced for patients living with were reduced for patients living with families, but increased for the remainder. families, but increased for the remainder. There was some evidence of improved There was some evidence of improved social function over 3 years (although this social function over 3 years (although this was not rated with masking) and almost was not rated with masking) and almost none of symptomatic benefit. none of symptomatic benefit. s 6 8 s 6 8 Do drug and psychological Do drug and psychological treatments enhance each other? treatments enhance each other?
It has been suggested that the effect of It has been suggested that the effect of family intervention is independent of family intervention is independent of medication (Kuipers medication (Kuipers et al et al, 1999) , but it , 1999), but it may be that optimal antipsychotic treatmay be that optimal antipsychotic treatment can benefit non-drug therapy. Examment can benefit non-drug therapy. Examples exist in the literature of how ples exist in the literature of how psychological treatments can enhance the psychological treatments can enhance the effect of drug treatments, or vice versa. A effect of drug treatments, or vice versa. A good example of how a psychological treatgood example of how a psychological treatment can enhance the effect of a drug treatment can enhance the effect of a drug treatment in schizophrenia is the compliance ment in schizophrenia is the compliance therapy trial of Kemp therapy trial of Kemp et al et al (1998) . The (1998). The observed reduction in relapse rates in the observed reduction in relapse rates in the experimental treatment group was not due experimental treatment group was not due to any direct effect of psychological treatto any direct effect of psychological treatment but rather an improved efficiency of ment but rather an improved efficiency of the pharmacological treatment. Conversely, the pharmacological treatment. Conversely, a good example of how an antipsychotic a good example of how an antipsychotic drug treatment can enhance the effect of a drug treatment can enhance the effect of a psychosocial treatment can be found in psychosocial treatment can be found in the double-blind randomised controlled the double-blind randomised controlled comparison between clozapine and halocomparison between clozapine and haloperidol in treatment-resistant patients peridol in treatment-resistant patients (Rosenheck (Rosenheck et al et al, 1998) . This trial con-, 1998). This trial confirmed the effectiveness of clozapine firmed the effectiveness of clozapine compared with haloperidol using a design compared with haloperidol using a design where the identity of the drugs was where the identity of the drugs was double-blind and patients allocated to halodouble-blind and patients allocated to haloperidol treatment received blood tests to peridol treatment received blood tests to mimic the monitoring system for clozapine. mimic the monitoring system for clozapine. The clinical trial was run in the context of a The clinical trial was run in the context of a mental health service setting where a range mental health service setting where a range of psychosocial treatments were on offer of of psychosocial treatments were on offer of varying degrees of complexity. A varying degrees of complexity. A post hoc post hoc analysis (Rosenheck analysis (Rosenheck et al et al, 1998) showed , 1998) showed that not only were the clozapine-treated pathat not only were the clozapine-treated patients more likely to show an improvement tients more likely to show an improvement in symptoms, but over the first 12 months in symptoms, but over the first 12 months of the trial they were progressively more of the trial they were progressively more likely to be able to take up psychosocial likely to be able to take up psychosocial treatments of greater complexity. This treatments of greater complexity. This represents an example of an effective drug represents an example of an effective drug treatment allowing individuals to use treatment allowing individuals to use psychological treatments more efficiently. psychological treatments more efficiently. There may be different expectations after There may be different expectations after termination of treatment. Relapse after distermination of treatment. Relapse after discontinuing drug treatment implies efficacy continuing drug treatment implies efficacy of the drug and the need for continual treatof the drug and the need for continual treatment, whereas release after stopping a psyment, whereas release after stopping a psychological treatment implies a failure to chological treatment implies a failure to maintain treatment gains. maintain treatment gains.
Can psychological treatments work Can psychological treatments work in the absence of drug treatments? in the absence of drug treatments?
Psychological interventions have always Psychological interventions have always been investigated as adjuncts to antibeen investigated as adjuncts to antipsychotic medication. The evidence for psychotic medication. The evidence for the efficacy of drug treatment is so well the efficacy of drug treatment is so well established that it may be ethically dubious established that it may be ethically dubious to attempt to test empirically whether to attempt to test empirically whether psychological treatments on their own are psychological treatments on their own are effective. One new area may throw light effective. One new area may throw light on this. A small number of studies have exon this. A small number of studies have examined the possibility of detecting individamined the possibility of detecting individuals in the prodromal stage, prior to the uals in the prodromal stage, prior to the development of full psychosis. Yung development of full psychosis. Yung et al et al (1998) have developed operational criteria (1998) have developed operational criteria to identify four subgroups at ultra-high risk to identify four subgroups at ultra-high risk of incipient psychosis. The improved ability of incipient psychosis. The improved ability to define high risk accurately has led to the to define high risk accurately has led to the possibility of intervention to prevent possibility of intervention to prevent psychosis in this group. psychosis in this group.
Three clinical trials have reported interThree clinical trials have reported interim or final results. McGorry im or final results. McGorry et al et al (2002) in (2002) in Melbourne found that specific pharmacoMelbourne found that specific pharmacotherapy (low-dose risperidone) plus CBT, therapy (low-dose risperidone) plus CBT, in comparison with supportive therapy in comparison with supportive therapy and case management, reduced the risk of and case management, reduced the risk of early transition to psychosis in an open, early transition to psychosis in an open, randomised trial of 59 young people at randomised trial of 59 young people at ultra-high risk. There was reduction in ultra-high risk. There was reduction in progression to psychosis at end of the 6-progression to psychosis at end of the 6-month treatment, but not at follow-up after month treatment, but not at follow-up after a further 6-month period of no treatment. a further 6-month period of no treatment. However, the relative contribution of However, the relative contribution of psychotherapy could not be determined psychotherapy could not be determined since theirs was a combined treatment. since theirs was a combined treatment. Woods Woods et al et al (2003) at Yale compared (2003) at Yale compared olanzapine with placebo double-blind in olanzapine with placebo double-blind in 60 individuals at ultra-high risk. Interim 60 individuals at ultra-high risk. Interim data at 1 year showed that olanzapine data at 1 year showed that olanzapine was more effective than placebo in reducing was more effective than placebo in reducing the prodromal symptoms themselves, with the prodromal symptoms themselves, with a trend towards reduction in transition to a trend towards reduction in transition to psychosis v. monitoring monitoring in 58 individuals from the same group at in 58 individuals from the same group at ultra-high risk. Participants were assessed ultra-high risk. Participants were assessed for suitability and monitored on a monthly for suitability and monitored on a monthly basis using the PANSS, which was also used basis using the PANSS, which was also used to determine transition. Full details regardto determine transition. Full details regarding entry criteria, study design and treating entry criteria, study design and treatment protocol have been reported ment protocol have been reported (Morrison (Morrison et al et al, 2002 ). An interim analysis , 2002 ). An interim analysis of the rate of transition to psychosis of the rate of transition to psychosis suggested an effect of CBT in reducing suggested an effect of CBT in reducing transmission and reducing severity of subtransmission and reducing severity of subclinical symptoms (Morrison clinical symptoms (Morrison et al et al, 2002 (Morrison et al et al, ). , 2002 ). This will be, to our knowledge, the first This will be, to our knowledge, the first study to attempt to evaluate whether study to attempt to evaluate whether CBT alone is effective in any stage of CBT alone is effective in any stage of the psychotic disorder (in this case, the psychotic disorder (in this case, preventing the progression of subclinical preventing the progression of subclinical symptoms in the absence of drug treatsymptoms in the absence of drug treatment). Combining data from these trials ment). Combining data from these trials will provide information about the relative will provide information about the relative acceptability, safety and efficacy of drug acceptability, safety and efficacy of drug and non-drug treatments in this emerging and non-drug treatments in this emerging area. area.
CONCLUSIONS CONCLUSIONS
A range of psychological interventions now A range of psychological interventions now exists for established psychotic disorders exists for established psychotic disorders and there is a rationale for their use during, and there is a rationale for their use during, following and even prior to the first following and even prior to the first episode, although formal evaluations are episode, although formal evaluations are needed. User and carer preferences for needed. User and carer preferences for available treatments is an issue that deavailable treatments is an issue that deserves further study, and the mental health serves further study, and the mental health needs of carers is a legitimate area of study needs of carers is a legitimate area of study in its own right. Combining interventions, in its own right. Combining interventions, such as CBT and family interventions, is such as CBT and family interventions, is an approach that needs to be evaluated. an approach that needs to be evaluated. At least 80% of people in their first episode At least 80% of people in their first episode will achieve good remission relatively will achieve good remission relatively quickly, but at least 80% will relapse by 5 quickly, but at least 80% will relapse by 5 years. Preventing or ameliorating first reyears. Preventing or ameliorating first relapse will be of crucial importance. Rates lapse will be of crucial importance. Rates of non-adherence to drug treatment are of non-adherence to drug treatment are high in this group and the possible role of high in this group and the possible role of intermittent, targeted drug treatment (Gaeintermittent, targeted drug treatment (Gaebel bel et al et al, 2002) , in tandem with psychologi-, 2002), in tandem with psychological strategies aimed at relapse prevention cal strategies aimed at relapse prevention (Gumley (Gumley et al et al, 2003) , needs to be assessed. , 2003), needs to be assessed. Where early intervention services are to be Where early intervention services are to be set up, it is important to have clear evidence set up, it is important to have clear evidence about the effectiveness of treatment for about the effectiveness of treatment for individuals in contact with the service. individuals in contact with the service.
APPENDIX APPENDIX
Design characteristics Design characteristics of a high-quality psychological of a high-quality psychological treatment trial treatment trial (a) (a) Large, representative sample from a clinically Large, representative sample from a clinically relevant, specified population relevant, specified population Kuipers, E., Bebbington, P., Pilling, S., Kuipers, E., Bebbington, P., Pilling, S., et al et al (1999) 
